Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$279.27 USD

279.27
2,445,750

-5.82 (-2.04%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $279.37 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (41 out of 247)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Urmimala Biswas headshot

CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?

by Urmimala Biswas

CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.

Zacks Equity Research

The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends

by Zacks Equity Research

Costco eyes 11.3% EPS growth in 2025, Chubb boosts income outlook, and Cigna posts strong Q1 as Zacks spotlights five standout stocks.

Mark Vickery headshot

Top Research Reports for Costco, Chubb & Cigna

by Mark Vickery

Zacks highlights strong prospects for COST, CB, and CI, with Costco's steady growth, Chubb's strategic expansion, and Cigna's solid Q1 performance amid margin pressures.

Zacks Equity Research

CI's Unit Unveils Offering to Expand Access to GLP-1 Medications

by Zacks Equity Research

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors.

Urmimala Biswas headshot

CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?

by Urmimala Biswas

CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.

Mark Vickery headshot

Markets Mostly Higher: Dow Kept Down by UNH Selling

by Mark Vickery

While UnitedHealthcare fights another unforeseen headwind, NVIDIA helped the Nasdaq cruise higher.

Zacks Equity Research

Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength

by Zacks Equity Research

CI increases adjusted earnings guidance for 2025 to $29.60 per share from the previous estimate of $29.50.

Zacks Equity Research

Cigna (CI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Cigna (CI) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Cigna (CI) delivered earnings and revenue surprises of 5.48% and 7.66%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Declining Medical Customers Affect Cigna's Q1 Earnings?

by Zacks Equity Research

CI's first-quarter results are likely to have benefited from growing pharmacy revenues and fees.